search
Back to results

An Assessment of the Feasibility and Safety of Conservative Oxygen Therapy in Critically Ill Patients

Primary Purpose

Critical Illness

Status
Completed
Phase
Phase 1
Locations
Australia
Study Type
Interventional
Intervention
conservative O2 therapy
standard care
Sponsored by
Austin Health
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Critical Illness focused on measuring oxygen, critical illness, mechanical ventilation

Eligibility Criteria

18 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Mechanical ventilation
  • expected to be ventilated until the day after tomorrow (a tiem frame of, on average 48 hours)

Exclusion Criteria:

  • expected to be off mechanical ventilation today or tomorrow
  • carbon monoxide poisoning
  • necrotizing fasciitis

Sites / Locations

  • Austin Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Active Comparator

Arm Label

standard care

conservative O2 therapy

Arm Description

normal treatment

a value of 90-92% O2 saturation will be targeted

Outcomes

Primary Outcome Measures

Difference in PaO2/FiO2 ratio from baseline to worst value
Pao2/FiO2 ratio will be measured regularly and compared during standard care and the intervention period (a time frame of, on average, 10 days)

Secondary Outcome Measures

Lactate
blood lactate will be measured regularly and assessed during standard care and the intervention period

Full Information

First Posted
September 7, 2012
Last Updated
July 9, 2013
Sponsor
Austin Health
search

1. Study Identification

Unique Protocol Identification Number
NCT01684124
Brief Title
An Assessment of the Feasibility and Safety of Conservative Oxygen Therapy in Critically Ill Patients
Official Title
A Before-and-after Assessment of Conservative Oxygen Therapy vs. Standard Care in Critically Ill Mechanically Ventilated Patients
Study Type
Interventional

2. Study Status

Record Verification Date
July 2013
Overall Recruitment Status
Completed
Study Start Date
March 2012 (undefined)
Primary Completion Date
March 2013 (Actual)
Study Completion Date
March 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Austin Health

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The investigators hypothesize that it is feasible and safe to deliver a conservative approach to oxygen therapy in mechanically ventilated critically ill patients (a tiem frame of, on average,10 days).
Detailed Description
Identify patients likely to require ventilation until the day after tomorrow (a time frame of 36 hours of average) Deliver a conservative oxygen therapy protocol while in ICU (a time frame on average of 10 days) Target an oxygen saturation between 90 and 92% Adjust FiO2 to achieve target SaO2 at all times Assess percentage of time patient is within target Assess for safety of this approach

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Critical Illness
Keywords
oxygen, critical illness, mechanical ventilation

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1, Phase 2
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
105 (Actual)

8. Arms, Groups, and Interventions

Arm Title
standard care
Arm Type
Placebo Comparator
Arm Description
normal treatment
Arm Title
conservative O2 therapy
Arm Type
Active Comparator
Arm Description
a value of 90-92% O2 saturation will be targeted
Intervention Type
Other
Intervention Name(s)
conservative O2 therapy
Intervention Description
target lower O2 saturation
Intervention Type
Other
Intervention Name(s)
standard care
Primary Outcome Measure Information:
Title
Difference in PaO2/FiO2 ratio from baseline to worst value
Description
Pao2/FiO2 ratio will be measured regularly and compared during standard care and the intervention period (a time frame of, on average, 10 days)
Time Frame
10 days
Secondary Outcome Measure Information:
Title
Lactate
Description
blood lactate will be measured regularly and assessed during standard care and the intervention period
Time Frame
10 days
Other Pre-specified Outcome Measures:
Title
arrhythmias
Description
patients will have continuous ECG monitoring and arrhythmias will be recorded in the two groups
Time Frame
10 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Mechanical ventilation expected to be ventilated until the day after tomorrow (a tiem frame of, on average 48 hours) Exclusion Criteria: expected to be off mechanical ventilation today or tomorrow carbon monoxide poisoning necrotizing fasciitis
Facility Information:
Facility Name
Austin Hospital
City
Melbourne
State/Province
Victoria
ZIP/Postal Code
3079
Country
Australia

12. IPD Sharing Statement

Citations:
PubMed Identifier
26718090
Citation
Eastwood GM, Tanaka A, Espinoza ED, Peck L, Young H, Martensson J, Zhang L, Glassford NJ, Hsiao YF, Suzuki S, Bellomo R. Conservative oxygen therapy in mechanically ventilated patients following cardiac arrest: A retrospective nested cohort study. Resuscitation. 2016 Apr;101:108-14. doi: 10.1016/j.resuscitation.2015.11.026. Epub 2015 Dec 21.
Results Reference
derived

Learn more about this trial

An Assessment of the Feasibility and Safety of Conservative Oxygen Therapy in Critically Ill Patients

We'll reach out to this number within 24 hrs